packagePemigatinib

pemigatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pemigatinib is a protein kinase inhibitor used to treat cholangiocarcinoma. It is an approved cancer medicine and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q96398739 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pemigatinib
ATC codes:L01EN02
DrugBank:DB15102
PubChem CID:86705695
Wikidata:Q96398739
formula:C24H27F2N5O4
molar mass:487.507 g/mol (PubChem CID 86705695)
logP:1.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown